Literature DB >> 9577283

Complement and contact activation in term neonates after fetal acidosis.

J Sonntag1, M H Wagner, E Strauss, M Obladen.   

Abstract

AIMS: To evaluate complement and contact activation after fetal acidosis.
METHODS: Fifteen term neonates with hypoxic-ischaemic encephalopathy after umbilical arterial pH < 7.10 were compared with 15 healthy neonates with umbilical arterial pH > 7.20. Determinations of the complement function and C1-inhibitor activity were performed as kinetic tests 22-28 hours after birth. C1q, C1-inhibitor, and factor B concentrations were determined by radial immunodiffusion and those of C3a, C5a, and factor XIIa by enzyme immunoabsorbent assay.
RESULTS: Median complement function (46 vs 73%), C1q (4.3 vs 9.1 mg/dl), and factor B (5.2 vs 7.7 mg/dl) decreased after fetal acidosis. The activated split products C3a (260 vs 185 micrograms/l), C5a (5.0 vs 0.6 micrograms/l), and factor XIIa (3.2 vs 1.3 micrograms/l) increased in the neonates after fetal acidosis. No differences were found in the concentration and activity of C1-inhibitor.
CONCLUSIONS: Complement and contact activation occurred in the newborns with hypoxic-ischaemic encephalopathy. Activation of these systems generates mediators which can trigger inflammation and tissue injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577283      PMCID: PMC1720767          DOI: 10.1136/fn.78.2.f125

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  26 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 2.  Physiology and pathophysiology of complement: progress and trends.

Authors:  B P Morgan
Journal:  Crit Rev Clin Lab Sci       Date:  1995       Impact factor: 6.250

Review 3.  Complement activation and inhibition in myocardial ischemia and reperfusion injury.

Authors:  J W Homeister; B R Lucchesi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

4.  An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma.

Authors:  R P Ford; M P Esnouf; A I Burgess; A Sarphie
Journal:  J Immunoassay       Date:  1996-05

Review 5.  Complement, neutrophils and free radicals: mediators of reperfusion injury.

Authors:  B R Lucchesi
Journal:  Arzneimittelforschung       Date:  1994-03

6.  Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion.

Authors:  M Buerke; T Murohara; A M Lefer
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

7.  Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion.

Authors:  R E Chávez-Cartaya; G P DeSola; L Wright; N V Jamieson; D J White
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

8.  Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.

Authors:  A Väkevä; B P Morgan; I Tikkanen; K Helin; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children.

Authors:  K Saatvedt; H Lindberg; O R Geiran; S Michelsen; A O Aasen; T Pedersen; T E Mollnes
Journal:  Scand J Clin Lab Invest       Date:  1995-02       Impact factor: 1.713

10.  Birth asphyxia: incidence, clinical course and outcome in a Swedish population.

Authors:  E Thornberg; K Thiringer; A Odeback; I Milsom
Journal:  Acta Paediatr       Date:  1995-08       Impact factor: 2.299

View more
  8 in total

1.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 2.  Dysfunction of innate immunity and associated pathology in neonates.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 5.319

3.  In-vitro activation of complement system by lactic acidosis in newborn and adults.

Authors:  F Hecke; T Hoehn; E Strauss; M Obladen; J Sonntag
Journal:  Mediators Inflamm       Date:  2001-02       Impact factor: 4.711

Review 4.  Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH.

Authors:  Hany Ibrahim Kenawy; Ismet Boral; Alan Bevington
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

Review 5.  Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage.

Authors:  Eridan Rocha-Ferreira; Mariya Hristova
Journal:  Front Immunol       Date:  2015-02-12       Impact factor: 7.561

6.  Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Claudia Sisa; Qudsiyah Agha-Shah; Balpreet Sanghera; Ariela Carno; Cordula Stover; Mariya Hristova
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

7.  The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis.

Authors:  Meredith A Achey; Uttara P Nag; Victoria L Robinson; Christopher R Reed; Gowthami M Arepally; Jerrold H Levy; Elisabeth T Tracy
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

8.  Acidosis activates complement system in vitro.

Authors:  M Emeis; J Sonntag; C Willam; E Strauss; M M Walka; M Obladen
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.